The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition

Current Opinion in Immunology
Christoph GarbersStefan Rose-John

Abstract

Interleukin-6 has long been recognized as a prototypic pro-inflammatory cytokine that is involved in the pathogenesis of all inflammatory diseases. Activation of the gp130 homodimer by IL-6 leads to the initiation of Jak/STAT signaling, a pathway that is often constitutively switched on in inflammatory malignancies. However, a plethora of studies in the last decade has convincingly shown that only signaling via the soluble IL-6R (trans-signaling) accounts for the deleterious effects of IL-6, whereas classic signaling via the membrane-bound receptor is essential for the regenerative and anti-bacterial effects of IL-6 (classic signaling). In this review, we highlight recent developments in the field of IL-6 research, and specifically focus on advances towards a safe and specific inhibition of IL-6 trans-signaling.

References

May 23, 1998·Annual Review of Immunology·W J Leonard, J J O'Shea
Dec 20, 2000·European Journal of Biochemistry·T JostockS Rose-John
Dec 21, 2004·Biochemical and Biophysical Research Communications·Jürgen SchellerStefan Rose-John
Mar 18, 2005·Annual Review of Immunology·Tadamitsu Kishimoto
Oct 3, 2009·Nature Reviews. Rheumatology·Peter C Taylor, Marc Feldmann
Nov 9, 2010·Nature Immunology·Jason S StumhoferChristopher A Hunter
Dec 15, 2010·European Journal of Cell Biology·Athena ChalarisJürgen Scheller
Feb 8, 2011·Biochimica Et Biophysica Acta·Jürgen SchellerStefan Rose-John
Sep 2, 2011·The Journal of Clinical Investigation·Simon A JonesStefan Rose-John
Sep 14, 2011·Annual Review of Pharmacology and Toxicology·Toshio TanakaTadamitsu Kishimoto
Nov 15, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Harald SchuettKarsten Grote
Nov 23, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Denada DibraShulin Li
Feb 7, 2012·Nature Immunology·Lauren W CollisonDario A A Vignali
Feb 14, 2012·Expert Opinion on Therapeutic Targets·Georg H Waetzig, Stefan Rose-John
Mar 17, 2012·Lancet·UNKNOWN IL6R Genetics Consortium Emerging Risk Factors CollaborationJohn Danesh
Mar 17, 2012·Lancet·UNKNOWN Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) ConsortiumJuan Pablo Casas
May 19, 2012·Cytokine & Growth Factor Reviews·Christoph GarbersJürgen Scheller
Nov 9, 2012·International Journal of Biological Sciences·Stefan Rose-John
Feb 22, 2013·The Journal of Clinical Investigation·Hong ZhangHana Algül
Dec 12, 2013·Seminars in Immunology·Jürgen SchellerStefan Rose-John
Jan 15, 2014·Seminars in Immunology·Jeffrey J BabonNicos A Nicola
Feb 14, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Iain L CampbellJuan Hidalgo
Mar 13, 2014·Seminars in Immunology·Qing ChangJacqueline Bromberg
Apr 20, 2014·Nature Medicine·Ren-Xi WangCharles E Egwuagu
Jun 29, 2014·The Journal of Biological Chemistry·Jan SommerJürgen Scheller
Jul 6, 2014·Cytokine·Janina WolfChristoph Garbers
Aug 20, 2014·Nature Reviews. Rheumatology·Leonard H Calabrese, Stefan Rose-John
Sep 6, 2014·Cold Spring Harbor Perspectives in Biology·Toshio TanakaTadamitsu Kishimoto
Sep 10, 2014·Cell Reports·Jan P BöttcherPercy A Knolle
Sep 27, 2014·PloS One·Samadhi Aparicio-SiegmundChristoph Garbers
Nov 11, 2014·The Journal of Clinical Investigation·Tobias DechowUlrich Keller
Jan 27, 2015·Trends in Immunology·Jan MauerJens C Brüning
Feb 7, 2015·Journal of the American Society of Nephrology : JASN·Michael LuigOliver M Steinmetz

❮ Previous
Next ❯

Citations

Feb 16, 2016·Cell Reports·Juliane LokauChristoph Garbers
Dec 17, 2015·Annual Review of Physiology·Jennifer C JonesPeter J Dempsey
Feb 13, 2016·Journal of Hepatology·Dirk Schmidt-Arras, Stefan Rose-John
Feb 11, 2016·Seminars in Cell & Developmental Biology·Teresa A ZimmersAndrea Bonetto
Jan 8, 2016·Digestive Diseases and Sciences·Shin HamadaTooru Shimosegawa
Feb 6, 2016·Expert Opinion on Biological Therapy·Jessica L Turnier, Hermine I Brunner
Aug 5, 2015·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Ichiro N Maruyama
Jul 22, 2015·Cytokine & Growth Factor Reviews·Samadhi Aparicio-Siegmund, Christoph Garbers
Jan 7, 2017·PLoS Biology·Steffen RiethmuellerChristoph Garbers
Feb 6, 2017·Biochemical and Biophysical Research Communications·Samadhi Aparicio-SiegmundChristoph Garbers
Mar 10, 2017·Expert Opinion on Investigational Drugs·Angela MauroRolando Cimaz
Mar 28, 2017·Biomolecules·A G M MostofaKalkunte S Srivenugopal
Jan 15, 2016·Medicinal Research Reviews·Claus Hellerbrand, Ramin Massoumi
Mar 3, 2017·Mediators of Inflammation·Mario Luca MorieriGiovanni Zuliani
Jun 21, 2017·Biochimica Et Biophysica Acta. Molecular Cell Research·Juliane LokauChristoph Garbers
Jul 5, 2017·Clinical Pharmacology and Therapeutics·Stefan Rose-John
Dec 1, 2017·International Journal of Molecular Sciences·Sean P Didion
Dec 26, 2017·Journal of Functional Morphology and Kinesiology·Graham Akeson, Charles J Malemud
Feb 23, 2018·Current Allergy and Asthma Reports·Joseph M Carrington, Jill A Poole
Mar 1, 2018·Immunology and Cell Biology·Dominik Rückerl, Paula I Seoane
May 28, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Victoria JefferyAnastasia Sobolewski
Oct 19, 2017·Restorative Neurology and Neuroscience·Klaus Heese
May 17, 2018·Pulmonary Circulation·Levi D MastonLaura V Gonzalez Bosc
Jul 28, 2018·Cardiovascular Research·Louise ZieglerBruna Gigante
Oct 14, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bofeng LiTerrence L Geiger
Dec 24, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Caroline M PercopoHelene F Rosenberg
Jul 18, 2018·Journal of Molecular Cell Biology·Daniëlle R J VerboogenGeert van den Bogaart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Related Papers

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Claudia DruckerStefan Rose-John
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Olga BraunStefan Rose-John
© 2022 Meta ULC. All rights reserved